... it based its decision on medical studies of OxyContin, reports of abuse and misuse, public comments and petitions. Stamford, Connecticut-based Purdue said in a statement that the new labeling will provide "important information to health care ...
via Stamford Newswire http://www.canada.com/health/OxyContin+patent+expires+says+generic+versions+must+contain+changes/8251199/story.html
via Stamford Newswire http://www.canada.com/health/OxyContin+patent+expires+says+generic+versions+must+contain+changes/8251199/story.html
No comments:
Post a Comment